These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28237154)

  • 1. Outcomes of bilateral sequential implantation of the Boston keratoprosthesis type 1.
    Vaillancourt L; Papanagnu E; Elfekhfakh M; Fadous R; Harissi-Dagher M
    Can J Ophthalmol; 2017 Feb; 52(1):80-84. PubMed ID: 28237154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Boston Keratoprosthesis type 1 as primary penetrating corneal procedure.
    Fadous R; Levallois-Gignac S; Vaillancourt L; Robert MC; Harissi-Dagher M
    Br J Ophthalmol; 2015 Dec; 99(12):1664-8. PubMed ID: 26034079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications associated with Boston keratoprosthesis type 1 and glaucoma drainage devices.
    Robert MC; Pomerleau V; Harissi-Dagher M
    Br J Ophthalmol; 2013 May; 97(5):573-7. PubMed ID: 23435225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boston type 1 keratoprosthesis: the CHUM experience.
    Robert MC; Harissi-Dagher M
    Can J Ophthalmol; 2011 Apr; 46(2):164-8. PubMed ID: 21708085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
    Greiner MA; Li JY; Mannis MJ
    Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Visual Outcomes, Complications, and Retention of the Boston Type I Keratoprosthesis.
    Aravena C; Yu F; Aldave AJ
    Cornea; 2018 Jan; 37(1):3-10. PubMed ID: 28990994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Aurolab Keratoprosthesis (KPro) versus the Boston Type I Kpro: 5-year Clinical Outcomes in 134 Cases of Bilateral Corneal Blindness.
    Basu S; Serna-Ojeda JC; Senthil S; Pappuru RR; Bagga B; Sangwan V
    Am J Ophthalmol; 2019 Sep; 205():175-183. PubMed ID: 30905723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual Outcomes and Complications of Type I Boston Keratoprosthesis in Children: A Retrospective Multicenter Study and Literature Review.
    Fung SSM; Jabbour S; Harissi-Dagher M; Tan RRG; Hamel P; Baig K; Ali A
    Ophthalmology; 2018 Feb; 125(2):153-160. PubMed ID: 28807636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
    Fadlallah A; Atallah M; Cherfan G; Awwad ST; Syed ZA; Melki SA
    Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glaucoma associated with Boston type I keratoprosthesis.
    Kamyar R; Weizer JS; de Paula FH; Stein JD; Moroi SE; John D; Musch DC; Mian SI
    Cornea; 2012 Feb; 31(2):134-9. PubMed ID: 22134402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boston type I keratoprosthesis versus penetrating keratoplasty following a single failed corneal graft.
    El-Khoury J; Khair D; Daoud R; Thompson P; Racine L; Harissi-Dagher M
    Eye (Lond); 2023 Feb; 37(3):486-491. PubMed ID: 35169272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glaucoma Risk Factors and Outcomes Following Boston Keratoprosthesis Type 1 Surgery.
    Geoffrion D; Harissi-Dagher M
    Am J Ophthalmol; 2021 Jun; 226():56-67. PubMed ID: 33493469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boston keratoprosthesis type 1 device leak.
    Najem K; Sebag M; Harissi-Dagher M
    Can J Ophthalmol; 2014 Feb; 49(1):106-8. PubMed ID: 24513367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes following Boston type 1 keratoprosthesis implantation in aniridia patients at the University of Montreal.
    Hassanaly SI; Talajic JC; Harissi-Dagher M
    Am J Ophthalmol; 2014 Aug; 158(2):270-276.e1. PubMed ID: 24844976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes following primary versus secondary Boston keratoprosthesis type 1 implantation.
    Nayman T; Bostan C; Szigiato AA; Harissi-Dagher M
    Br J Ophthalmol; 2022 Jul; 106(7):935-940. PubMed ID: 33622700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the Role and Timing of Glaucoma Surgery in Boston Keratoprosthesis Type 1 Patients.
    Geoffrion D; Hassanaly SI; Marchand M; Daoud R; Agoumi Y; Harissi-Dagher M
    Am J Ophthalmol; 2022 Mar; 235():249-257. PubMed ID: 34543660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boston Keratoprosthesis Type 1: A Randomized Controlled Trial of Fresh versus Frozen Corneal Donor Carriers with Long-Term Follow-up.
    Muzychuk AK; Robert MC; Dao S; Harissi-Dagher M
    Ophthalmology; 2017 Jan; 124(1):20-26. PubMed ID: 27566854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes and complications of Boston keratoprosthesis type I implantation in unilateral versus bilateral corneal blindness.
    Touma S; Harissi-Dagher M
    Can J Ophthalmol; 2021 Apr; 56(2):130-136. PubMed ID: 33002416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of visual outcomes following Boston type 1 keratoprosthesis implantation.
    Ahmad S; Akpek EK; Gehlbach PL; Dunlap K; Ramulu PY
    Am J Ophthalmol; 2015 Apr; 159(4):739-47. PubMed ID: 25555801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitreoretinal Complications in Boston Keratoprosthesis Type 1.
    Khair D; Salimi A; Harissi-Dagher M
    Am J Ophthalmol; 2021 Nov; 231():101-108. PubMed ID: 34107311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.